Aviir provides cardio metabolic tests and services for the prevention and management of cardiovascular diseases.
Industries BiotechnologyHealth DiagnosticsPharmaceuticalHeadquarters Regions Greater Los Angeles Area, West Coast, Western US Closed Date Jan 1, 2014 Founded Date 2005 Operating Status Closed Last Funding Type Series B
Company Type For Profit
Contact Email clientservices@aviir.com Phone Number 9493331442
Aviir is a venture-funded biotechnology company developing cutting-edge, diagnostic tests enabling accurate diagnosis and prognosis of cardiovascular disease. The company’s proprietary technology is based on ten years of research at Stanford University, and combines the scientific founder’s deep understanding of biomarker assay development and
advanced biostatistics. Aviir has pursued an aggressive commercialization strategy, and initial products, including the MIRISK VP™ test, are currently on the market. The Aviir leadership team includes the founding scientists and highly experienced management.